We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

571 hedge funds and large institutions have $1.18B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2020 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 120 increasing their positions, 186 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,672% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $560K

9% less first-time investments, than exits

New positions opened: 68 | Existing positions closed: 75

2% less funds holding

Funds holding: 583 → 571 (-12)

9% less funds holding in top 10

Funds holding in top 10: 11 → 10 (-1)

35% less repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 186

37% less capital invested

Capital invested by funds: $1.89B → $1.18B (-$706M)

Holders
571
Holders Change
-12
Holders Change %
-2.06%
% of All Funds
11.52%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.2%
New
68
Increased
120
Reduced
186
Closed
75
Calls
$15.5M
Puts
$560K
Net Calls
+$15M
Net Calls Change
-$8.18M

Top Buyers

1
APM
Avidity Partners Management
Texas
+$48.3M
2
NCM
Nantahala Capital Management
Connecticut
+$44.1M
3
LCM
Laurion Capital Management
New York
+$22.1M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$20.3M
5
MP
Mangrove Partners
Connecticut
+$17.5M

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$44.2M
2
BCM
Beryl Capital Management
California
-$27.6M
3
ACM
Abrams Capital Management
Massachusetts
-$24M
4
EC
EcoR1 Capital
California
-$17M
5
Marshall Wace
Marshall Wace
United Kingdom
-$15.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
1
Laurion Capital Management
New York
$126M +$22.1M +7,745,865 +16%
FCM
2
Farallon Capital Management
California
$99.2M -$363K -127,000 -0.3%
PCM
3
Pentwater Capital Management
Florida
$85.7M -$44.2M -15,478,000 -29%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$54.3M +$20.3M +7,111,034 +42%
APM
5
Avidity Partners Management
Texas
$51M +$48.3M +16,897,991 +292%
CS
6
Credit Suisse
Switzerland
$48.6M +$5.6M +1,959,371 +10%
Viking Global Investors
7
Viking Global Investors
Connecticut
$41.4M -$1.62M -566,750 -3%
NCM
8
Nantahala Capital Management
Connecticut
$34.7M +$44.1M +15,437,336 New
ACM
9
Abrams Capital Management
Massachusetts
$33.3M -$24M -8,402,514 -36%
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$33.3M +$3.1M +1,084,159 +8%
DKCM
11
Davidson Kempner Capital Management
New York
$27.5M +$8.32M +2,914,489 +31%
MP
12
Mangrove Partners
Connecticut
$22.7M +$17.5M +6,139,668 +156%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$22.3M -$547K -191,701 -2%
JP Morgan Chase
14
JP Morgan Chase
New York
$18M -$7.1M -2,485,026 -22%
WIA
15
Wealthstreet Investment Advisors
Texas
$17.9M +$507K +177,366 +128%
AC
16
Aristeia Capital
Connecticut
$17.1M +$11M +3,843,728 +102%
HI
17
HBK Investments
Texas
$16.9M +$4.28M +1,500,000 +25%
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$16.8M +$7.14M +2,500,000 +51%
Citadel Advisors
19
Citadel Advisors
Florida
$16.1M -$7.94M -2,779,405 -28%
LP
20
LMR Partners
United Kingdom
$15.1M +$4.28M +1,500,000 +29%
CC
21
Casdin Capital
New York
$14.1M +$9.42M +3,300,000 +112%
TAL
22
TIG Advisors LLC
New York
$14M -$9.82M -3,440,010 -36%
TP
23
Third Point
New York
$13.5M – – –
AAM
24
Alpine Associates Management
Florida
$13.1M +$3.48M +1,218,700 +26%
Fidelity Investments
25
Fidelity Investments
Massachusetts
$12.4M -$2.46M -862,220 -13%
1
2 3 4 5

BMY.RT Hedge Fund Activity: Q3 2020 in Review

571 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q3 2020, worth a combined $1.18B — down 37% from $1.89B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of BMY.RT and 68 opened new positions — a net loss of 7 holders — while 186 trimmed existing stakes and 120 added.

The largest buyer was Avidity Partners Management, adding an estimated $48.3M. The largest seller was Pentwater Capital Management, cutting an estimated $44.2M.

  • 571 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q3 2020, down from 583 in Q2 2020.
  • Funds reported $1.18B of Bristol-Myers Squibb Company Contingent Value Rights stock for Q3 2020, down 37% quarter-over-quarter.
  • 68 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q3 2020 and 75 closed out, a net change of -7 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q3 2020 was Avidity Partners Management, an estimated $48.3M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q3 2020 was Pentwater Capital Management, an estimated $44.2M sold.

Based on aggregated 13F filings for Q3 2020.